Genetic variants underlying the neuro‐anatomical signatures of hypertension measured on structural MRI

Abstract

AbstractBackgroundHypertension (HTN) is associated with gray matter (GM) atrophy and increased white matter hyperintensity (WMH) burden, increasing their susceptibility to Alzheimer’s disease and related dementias. We developed a machine learning based model to quantify spatial patterns of abnormality recognizing HTN‐related brain changes (SPARE‐HTN) from structural magnetic resonance images (sMRI). We performed a genome wide association study (GWAS) to identify the genetic variants and associated biological traits that underlie the “expression” of HTN‐related brain changes, i.e., the individualized SPARE‐HTN index.MethodSPARE‐HTN model was trained on the large multi‐study iSTAGING dataset, with regional GM volumes from T1‐weighted images and lobar WMH volumes from T2‐weighted FLAIR images used as imaging features. GWAS was carried out in a subset of N = 7490 (46% Female, Age = 65.5±7 years) hypertensive participants from UK‐Biobank. A GWAS of SPARE‐HTN scores was run using linear regression with Plink, correcting for the top 40 genetic principal components, age, sex, and intracranial volume. Significant SNPs were identified and mapped to functional genes using the Functional Mapping and Annotation (FUMA) platform; and candidate SNPs were mapped to the GWAS catalog.ResultSPARE‐HTN was associated with regional atrophy most prominent in perisylvian and temporal cortex and increased WMH volumes, particularly in frontal white matter. SPARE‐HTN scores showed better discriminative power between normal and stage 1 participants (Cohen’s‐d effect size, d = 0.2) and stage 2 (d = 0.71) hypertensive participants when compared to total WMH volume (d = 0.04 and 0.38, respectively). GWAS identified N = 321 independently significant SNPs, of which a subset N = 46 candidate SNPs were mapped to 6 genes (ICA1L, CARF, WDR12, NBEAL1, KRT8P15, CYP20A1) in Chromosome 2 (Figure 2). These genes were previously reported to be associated with several cardiovascular conditions including coronary artery disease and stroke, and with increased WM damage on sMRI and diffusion MRI (Figure 3).ConclusionThe individualized imaging marker, SPARE‐HTN, was associated with genes relevant to HTN with traits including cardiovascular conditions and higher prevalence of WMH, and was more sensitive to HTN than total WMH volume. SPARE‐HTN is a useful tool to characterize HTN‐related brain changes and monitor treatment effects at an individual level.